MRK gets license to Ono stroke compound

Ono (Osaka, Japan) granted MRK worldwide rights outside of Japan, Korea and Taiwan to the intravenous formulation of its ONO-2506, a glutumate transporter uptake modulator in Phase II testing for acut...